Matches in SemOpenAlex for { <https://semopenalex.org/work/W2743180529> ?p ?o ?g. }
- W2743180529 endingPage "26" @default.
- W2743180529 startingPage "21" @default.
- W2743180529 abstract "The effectiveness of the combination chemotherapy of weekly paclitaxel and cetuximab has not yet been compared to that of the current standard regimen, EXTREME (combination of 5-fluorouracil, cisplatin and cetuximab). We retrospectively reviewed the clinical records of R/M SCCHN patients who received cetuximab-containing chemotherapy as a first-line therapy; from these, patients receiving a weekly paclitaxel and cetuximab regimen (cohort A) and the EXTREME regimen (cohort B) were extracted. The responses, prognoses and adverse events of these two cohorts were evaluated. A total of 86 patients were included (cohort A, 49; cohort B, 36). Patients with histories of platinum-based chemotherapy were more frequently given the cohort A treatment. Though the response rates were similar in the two cohorts (45% in cohort A and 51% in cohort B; p = 0.83), the progression-free survival (PFS) was significantly more favorable in cohort A by the log-rank test (6.0 months vs 5.0 months; p = 0.027). In the Cox-regression hazard analyses, male gender (hazard ratio [HR] = 2.1, p = 0.010), older age (≥ 70 yo) (HR = 5.0, p = 0.018), PS 0 (HR = 2.2, p = 0.027), no history of platinum chemotherapy (HR = 3.2, p = 0.003) and the presence of a tracheostomy (HR = 2.3, p = 0.039) were favorable factors within cohort A. In selected R/M SCCHN patients, the combination of weekly paclitaxel and cetuximab could be the better treatment option than the EXTREME regimen." @default.
- W2743180529 created "2017-08-17" @default.
- W2743180529 creator A5011368621 @default.
- W2743180529 creator A5018910129 @default.
- W2743180529 creator A5024947794 @default.
- W2743180529 creator A5027517929 @default.
- W2743180529 creator A5029219248 @default.
- W2743180529 creator A5049198126 @default.
- W2743180529 creator A5058697228 @default.
- W2743180529 creator A5075442750 @default.
- W2743180529 creator A5085075825 @default.
- W2743180529 creator A5087368848 @default.
- W2743180529 creator A5089037165 @default.
- W2743180529 creator A5090285315 @default.
- W2743180529 date "2017-10-01" @default.
- W2743180529 modified "2023-10-02" @default.
- W2743180529 title "A comparison of weekly paclitaxel and cetuximab with the EXTREME regimen in the treatment of recurrent/metastatic squamous cell head and neck carcinoma" @default.
- W2743180529 cites W1511486711 @default.
- W2743180529 cites W1984172283 @default.
- W2743180529 cites W1993159276 @default.
- W2743180529 cites W2014222076 @default.
- W2743180529 cites W2016882655 @default.
- W2743180529 cites W2040499562 @default.
- W2743180529 cites W2085935699 @default.
- W2743180529 cites W2102786252 @default.
- W2743180529 cites W2110664940 @default.
- W2743180529 cites W2112845420 @default.
- W2743180529 cites W2121960517 @default.
- W2743180529 cites W2124462445 @default.
- W2743180529 cites W2126671171 @default.
- W2743180529 cites W2132551046 @default.
- W2743180529 cites W2136871952 @default.
- W2743180529 cites W2152609192 @default.
- W2743180529 cites W2161238106 @default.
- W2743180529 cites W2161675417 @default.
- W2743180529 cites W2165385965 @default.
- W2743180529 cites W2401455386 @default.
- W2743180529 cites W2529484692 @default.
- W2743180529 cites W2559967187 @default.
- W2743180529 cites W2603415704 @default.
- W2743180529 doi "https://doi.org/10.1016/j.oraloncology.2017.07.022" @default.
- W2743180529 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28939072" @default.
- W2743180529 hasPublicationYear "2017" @default.
- W2743180529 type Work @default.
- W2743180529 sameAs 2743180529 @default.
- W2743180529 citedByCount "20" @default.
- W2743180529 countsByYear W27431805292018 @default.
- W2743180529 countsByYear W27431805292019 @default.
- W2743180529 countsByYear W27431805292020 @default.
- W2743180529 countsByYear W27431805292021 @default.
- W2743180529 countsByYear W27431805292022 @default.
- W2743180529 countsByYear W27431805292023 @default.
- W2743180529 crossrefType "journal-article" @default.
- W2743180529 hasAuthorship W2743180529A5011368621 @default.
- W2743180529 hasAuthorship W2743180529A5018910129 @default.
- W2743180529 hasAuthorship W2743180529A5024947794 @default.
- W2743180529 hasAuthorship W2743180529A5027517929 @default.
- W2743180529 hasAuthorship W2743180529A5029219248 @default.
- W2743180529 hasAuthorship W2743180529A5049198126 @default.
- W2743180529 hasAuthorship W2743180529A5058697228 @default.
- W2743180529 hasAuthorship W2743180529A5075442750 @default.
- W2743180529 hasAuthorship W2743180529A5085075825 @default.
- W2743180529 hasAuthorship W2743180529A5087368848 @default.
- W2743180529 hasAuthorship W2743180529A5089037165 @default.
- W2743180529 hasAuthorship W2743180529A5090285315 @default.
- W2743180529 hasConcept C121608353 @default.
- W2743180529 hasConcept C126322002 @default.
- W2743180529 hasConcept C141071460 @default.
- W2743180529 hasConcept C143998085 @default.
- W2743180529 hasConcept C207103383 @default.
- W2743180529 hasConcept C2776530083 @default.
- W2743180529 hasConcept C2776694085 @default.
- W2743180529 hasConcept C2776833033 @default.
- W2743180529 hasConcept C2778336483 @default.
- W2743180529 hasConcept C2779998722 @default.
- W2743180529 hasConcept C2781413609 @default.
- W2743180529 hasConcept C44249647 @default.
- W2743180529 hasConcept C50382708 @default.
- W2743180529 hasConcept C526805850 @default.
- W2743180529 hasConcept C71924100 @default.
- W2743180529 hasConcept C72563966 @default.
- W2743180529 hasConceptScore W2743180529C121608353 @default.
- W2743180529 hasConceptScore W2743180529C126322002 @default.
- W2743180529 hasConceptScore W2743180529C141071460 @default.
- W2743180529 hasConceptScore W2743180529C143998085 @default.
- W2743180529 hasConceptScore W2743180529C207103383 @default.
- W2743180529 hasConceptScore W2743180529C2776530083 @default.
- W2743180529 hasConceptScore W2743180529C2776694085 @default.
- W2743180529 hasConceptScore W2743180529C2776833033 @default.
- W2743180529 hasConceptScore W2743180529C2778336483 @default.
- W2743180529 hasConceptScore W2743180529C2779998722 @default.
- W2743180529 hasConceptScore W2743180529C2781413609 @default.
- W2743180529 hasConceptScore W2743180529C44249647 @default.
- W2743180529 hasConceptScore W2743180529C50382708 @default.
- W2743180529 hasConceptScore W2743180529C526805850 @default.
- W2743180529 hasConceptScore W2743180529C71924100 @default.
- W2743180529 hasConceptScore W2743180529C72563966 @default.
- W2743180529 hasLocation W27431805291 @default.